SPEAKER’S PROFILE
Drs. Jahja Santoso, Pharmacist
 Educational background :
Bandung Institute of Technology, Pharmacy college.
 Current Functions :

Owner and President Director of PT Sanbe Farma, the largest pharmaceutical
manufacturing company in Indonesia among more than 200 pharmaceutical companies.
(website : www.sanbe-farma.com)

Owner and President Director of PT Caprifarmindo Laboratories (website :
www.caprifarmindo.com)

Owner of Santosa Bandung International Hospital (website : www.santosahospital.com)

Owner and President Director of PT Bina San Prima, General Trading & Distributor
(website : www.binasanprima.com)

Owner of the Holiday Inn International Hotel in Bandung / Ibis Hotel in Semarang

Member Board of Trustee, Padjadjaran University

Honorary Title Prince of Central Java Kingdom

Founder of Santoso Charity Foundation with 75 orphanage houses and 2,000 students
with scholarship.

Honorary Consul of The Republic of Latvia, for West Java & Bali (Indonesia)

Owner of San Diamond Jewelry
Invest in
Presented by :
Drs. Jahja Santoso, Pharmacist
Honorary Consul of The Republic of Latvia
For West Java & Bali
June 07, 2011
INDONESIA
• Biggest archipelago country in the
world
- Island
: > 17,000
- Lands
: ± 2 million km2
- Sea
: ± 5,8 million km2
- Coastal line : ± 81,000 km
• Population : 240,000,000
people
• Hundreds of ethnics
• More than 750 languages & dialects
6,435 Km
• One of biggest democratic country
Snapshot of Indonesia’s Macro Condition
Snapshot of Indonesia’s Macro Condition
GDP (Qtr II-2010)
Foreign exchange (FX) Reserves
(Qtr II-2010)
Interest Rate (as per July ‘10)
Foreign Debt Ratio (Qtr II-2010)
Inflation (until September 2010)
6.0%
USD 76.3 Billion
6.50 %
28.3 %
5.28%
Note : Nominal per-capita GDP is expected to quadruple by 2020 as
per Standard Chartered
Source: Bank Indonesia, Investment Coordinating Board / BKPM
INDONESIA’S UNIQUE STRENGTHS AND
OPPORTUNITIES
KEY STRENGTHS
1. Dynamic and youthful population
• Of the 240 million people in Indonesia, over 50% of the
population is under 29 years old
• Rapidly urbanizing population provides for labor force
in centers of investment
• Dynamic labor market participation with a growth of
2.3 million people per year
INDONESIA’S UNIQUE STRENGTHS AND
OPPORTUNITIES
KEY STRENGTHS
2. Abundance of natural resources
Crude Oil
Key
Metrics
Over 3.5
billion
barrels of
proven
reserves
Natural
Gas
About 112
ton cubic
feet of
reserves
Thermal Geothermal
Coal
World’s
second
largest
exporter
Home to
40% of
world’s
resources
INDONESIA’S UNIQUE STRENGTHS AND
OPPORTUNITIES
KEY STRENGTHS
2. Abundance of natural resources
Palm oil
Key
World’s largest
Metrics exporter,
producing
about 19
million tons per
year
Cocoa
At 779
thousand
tons per
year, world’s
second
largest
producer
Tin
At 65 thousand
tons per year,
world’s second
largest producer
INDONESIA’S UNIQUE STRENGTHS AND
OPPORTUNITIES
KEY STRENGTHS
3. Burgeoning Domestic Market
 The services sector has grown over 16 percentage points
from 1998 to 2009.
 Private consumption accounts for 70% of GDP and has
increased by 5.3% in 2008
 Consumer confidence index rose by nearly 10% in November
2009 (year-on-year)
 Over 50% of the population live in urban areas and adopt a
modern lifestyle
INDONESIA’S UNIQUE STRENGTHS AND
OPPORTUNITIES
KEY STRENGTHS
4. Strategic Location and Increasing Global Presence
 Indonesia lies strategically in the intersection of the Pacific
Ocean, along the Malacca Straits and the Indian ocean
 Over half of all international shipping travel through Indonesian
waters
 The only country in South-east Asia that is a member of G-20
 An active and strong voice of developing countries in global
discussions on issues around climate change, global economy
architecture, etc
INDONESIA’S UNIQUE STRENGTHS AND
OPPORTUNITIES
KEY STRENGTHS
5. Increasingly skilled labor force
• Government is committed to making education a
priority:
 Education spending accounts for 16% of total
government expenditures
 University graduates are trained in technical fields
such as finance and economics (28%) or engineering
and sciences (27.5%)
• Labor cost is relatively low (USD 0.6 per hour), even as
compared to investment magnets China (USD 2.11 per
hour) and India (USD 1.03 per hour)
INDONESIA’S UNIQUE STRENGTHS AND
OPPORTUNITIES
KEY STRENGTHS
6. On-going reform in investment climate
Investment Law (2007)
- Equal Treatment for foreign & domestic investors
- No Minimum Capital Requirement
- Divestment not required
- Free to Repatriate Investment & Profit
- Legal Guarantee
- Dispute Settlement
- Investment Services
 Establishment of a one-door integrated service and a national
single window for investment, enhancing investment coordination
and facilitation.
 Listed as one of ten countries improving investor protections as
per Doing Business Report 2010 by IFC (International Finance
Corporation)

Stimulus
 Tax and Duties covered by government
 Income Tax Reduction for Individual & Geothermal
Development
 Speeding Up Infrastructure Development
 Discount Price for Power & Energy
 Intensify discussion on facilities for foreign
investments including integrated services and
reviewing of fiscal facilities
2010 Foreign Direct Investment (FDI) Confidence Index
Conclusion
 Indonesia with its big population, abundant
natural resources, on-going reform in investment
climate is a promising country for investment.
 Government has commitment to support
investment in Indonesia with its Investment Law
2007.
 Indonesia is ranked as the 20th FDI (Foreign Direct
Investment) destination country in 2010.
For further information, please contact :
* INDONESIA INVESTMENT COORDINATING BOARD
• Chairman : Gita I. Wirjawan
• Deputy Chairman of Investment Promotion :
Ir. Darmawan Dj., MA
• Website : www.bkpm.go.id
• Office Address :
Jl. Jend. Gatot Subroto No. 44, Jakarta 12190
P.O. Box 3186, Indonesia
Phone
: +62 21 5292 1334
Fax
: +62 21 5264 211
E-mail
: [email protected]
INDONESIAN PHARMACEUTICAL
OVERVIEW
Presented by :
Drs. Jahja Santoso, Pharmacist
Honorary Consul of The Republic of Latvia
For West Java & Bali
June 07, 2011
INDONESIAN CONDITION
Drug consumption
Per capita/year
•
•
•
•
Year
US $
2004
8.2
2005
8.8
2006
9.0
2007
10.0
2008
12.0
Hospitals
1,200
Total Doctors
40,000
– Specialist
10,000
– General Practitioner
24,000
– Dentist
6,000
– Ratio Doctor to Patient: Way below WHO standard
Primary Health Care
7,000
Pharmacies
7,000
HEALTH BUDGET IN INDONESIA
FROM YEAR TO YEAR
2005
IDR 5.8 trillion
2006
IDR 13.5 trillion
2007
IDR 15.1 trillion
2008
IDR 16 trillion
2009
IDR 19.3 trillion
2010
IDR 26 trillion
Source : from various sources
Note : USD 1 = Rp 9,000
Health Expenditure Comparison
in ASEAN countries
Country
Vietnam
Cambodia
Malaysia
Health Expenditure
(as % of GDP)
6.6
6.0
4.3
Laos
Thailand
Singapore
Philippines
3.6
3.5
3.4
3.3
Myanmar
Indonesia
2.3
2.2
INDONESIAN PHARMACEUTICAL
MARKET
 Pharma Market size in 2010 : around USD 4 Billion
 Market growth : 14.10 % per year
 There are presently 200 local and 35 foreign
pharmaceutical companies
 Patent Law: effective as of 1 January 2000
INDONESIAN PHARMACEUTICAL
MARKET
Pharma Market Characteristic :
 Capital Intensive
 High tech, Highly fragmented, Highly regulated
 Multiproduct line
 High imported content
 Small percentage of people covered by insurance
PHARMA MARKET TREND IN INDONESIA
2001-2007
Value in billion rupiah
GENERIC
ETHICAL DRUG
DRUG
Year
TOTAL MARKET
2001
12,850
7,891
1,547
2002
15,483
9,618
1,694
2003
17,458
10,829
1,819
2004
20,872
12,706
2,136
2005
23,629
14,675
2,529
2006
23,173
13,834
2,390
2007*)
25,027
11,899
2,222
Source : Bisnis Indonesia 12 Feb 2008
Note : USD 1 = Rp 9,000
BIG FIVE PHARMACEUTICAL COMPANIES IN
INDONESIA
Company
KALBE FARMA
SANBE FARMA
Market Share (%)
6.99
5.23
SOHO
4.03
DEXA MEDICA
3.76
TEMPO SCAN PACIFIC
3.55
Source : Suara Pembaruan daily newspaper, September 25, 2010
Share of OTC & Prescription - Pharma Market
OTC
33.0%
Prescription
67.0%
Total Registered Product: 15,911 Items
Source : IMS Health
PRESCRIPTION PHARMACEUTICAL MARKET
SHARE
Pharmacy (IPA 2009)
Kalbe Group
7%
Dexa Medica
Group
7%
Sanbe
9%
Pfizer Group
6%
Others
59%
Sanofi Aventis
4%
Interbat
3%
Novartis
5%
Source : IMS Health, Fiscal Year 2009 (Ethical)
PRESCRIPTION PHARMACEUTICAL MARKET
SHARE
Hospital (IHPA 2009)
Kalbe Group
11%
Dexa Medica
Group
9%
Sanbe
9%
Pfizer Group
4%
Others
57%
Sanofi Aventis
4%
Novartis
3%
Source : IMS Health, Fiscal Year 2009 (Ethical)
Pharos
3%
EXPORTED PHARMACEUTICAL PRODUCT FROM INDONESIA
2001-2005 AND JANUARY-JULY 2006 VALUE IN THOUSAND US$
HS
PRODUCT
2001
2002
2003
2004
2005
% Share % Trend JAN-JULY JAN-JULY % change
2005
2001-2005
2005
2006
2006/2005
3001 Glands etc dry & ext,
heparin, hum etc
subst nesoi
339
2,898
1,107
527
42
0.04
-44.52
12
13
3.63
3002 Human blood, animal
blood, antisera,
vaccines etc
3,848
7,380
6,878
10,999
7,044
7.26
17.45
4,886
5,737
17.41
3003 Medicaments nesoi
of mixtures, not
dosage etc form
15,706 18,923
23,735
20,230 15,158
15.62
-0.04
9,768
5,894
-39.66
3004 Medicaments nesoi,
mixed or not, in
dosage etc fm
44,382 46,289
60,074
76,606 64,933
66.91
13.48
41,198
43,509
5.61
3005 Bandages etc coated
etc or in retail medic
etc fm
6,622
2,487
2,549
1,323
1,644
1.69
-28.95
980
1,253
27.85
3006 Pharmaceutical
goods (specified
sterile prod etc.)
5,003
9,228
9,963
8,452
8,225
8.48
9.49
4,318
6,730
55.84
104,306 118,137 97,046 100.00
8.28
61,163
63,135
3.22
75,898 87,205
TOTAL
Source : Central Bureau of Statistics
IMPORTED PHARMACEUTICAL PRODUCTS TO INDONESIA FROM
COUNTRY OF ORIGIN in 2001-2005 AND JANUARY-JULY 2006
VALUE IN THOUSAND US$
NO.
COUNTRY
%
% SHARE % TREND JAN-JULY JAN-JULY
CHANGE
2005
2001-2005
2005
2006
2006/2005
2001
2002
2003
2004
2005
17,426
15,702
27,242
41,358
26,494
13.94
19.80
15,830
23,146
46.21
7,114
11,278
12,324
15,499
19,895
10.47
26.80
9,579
13,758
43.63
13,339
13,581
12,494
15,218
17,530
9.22
6.83
9,669
15,296
58.20
4 Switzerland
4,556
7,315
11,196
14,357
14,782
7.78
35.37
9,643
9,701
0.61
5 UK
5,124
6,295
9,043
9,469
13,035
6.86
25.55
7,603
8,214
8.04
6 Italy
3,538
4,352
5,123
8,168
11,255
5.92
34.23
7,184
7,519
4.66
7 Japan
2,404
3,845
4,205
6,167
10,232
5.38
40.06
4,381
5,833
33.16
784
3,309
6,293
6,967
9,048
4.76
75.69
5,707
7,541
32.13
2,721
4,656
3,458
5,125
8,469
4.45
26.71
3,944
5,875
48.96
4,074
6,002
7,668
8,698
8,412
4.43
19.98
4,545
7,662
68.58
Others
20,820
22,526
28,177
40,548
50,948
26.80
26.84
29,319
44,362
33.91
TOTAL
81,898
98,862
127,223
171,574
190,100
100.00
25.05
107,404
148,908
38.64
1 Germany
2 France
3 USA
8 South Korea
9 Belgium
10 Netherlands
Source : Central Bureau of Statistics
Pharmaceutical Business Condition
o The Indonesia Pharmaceutical market is still potential
enough considering the population number, GDP and
drug consumption.
o Industry needs to invest in order to comply with cGMP
regulation
o Minister of Health Decree No. 1010/Menkes/PER/XI/2008:
Registration of imported drug shall be performed by
domestic pharmaceutical industry with written
authorization from foreign pharmaceutical industry.
Technology transfer shall be done within 5 years the
latest in order that the product be produced locally.
o Regulation about National Social Security System / SJSN
and Health Insurance for poor population.
OPPORTUNITY FOR
PHARMACEUTICAL INDUSTRY
Opportunity to grow is still available for
pharmaceutical industry in Indonesia :
 Indonesia as one country with the lowest
medicine consumption per capita in ASEAN
 Indonesian vision to be high income country in
2030 (US$18,000 per capita)
 Indonesian people is projected to be 285 million
in 2030
Source : Yayasan Indonesia Forum 2007; Bisnis Farmasi 2007, WordPress.com
30
For Further information, please contact :
GP Farmasi (Indonesian Pharmaceutical
Association)
The only pharmaceutical association in Indonesia:
covering Manufacturer, Distributor, Pharmacy & Drug
Stores based on Ministry of Health Decree no 222/1969
Members:
 Foreign
 National
 Wholesaler
 Pharmacy
 Drug store
33
172 (4 State Owned)
2,463
7,671
5,513 (Licenced)
 Chairman of GP Farmasi :
Mr. Anthony CH. Sunarjo, MBA.
(e-mail address : [email protected])
 Executive Secretary :
Buddy Nataatmadja
(e-mail address : [email protected])
Website : www.gpfarmasi.org
Office address :
Jl. Angkasa No. 20 A
Jakarta – 10620
Indonesia
E-mail
Phone
Fax
: [email protected]
: +62 21 4203040
: +62 21 4203047; +62 21 4203048
NATIONAL AGENCY OF DRUG AND FOOD
CONTROL (NADFC)
as National Regulatory Authority in Indonesia,
consistent with :
 Good Drug Regulatory Practices (GDRP);
QA ; Standardization; Self-regulatory Code;
Inspection and Audit
 Good Management Practices (GMgP);
Transparancies and fairness; SOPs; Costrecovery; incentive/ disincentive
REGULATORY SYSTEM
for Pharmaceuticals in Indonesia
• Consistency in regulation
• Transparency of services
Multi National
Companies
~
Domestic
Companies
No discrimination on Standard and Requirement
PHARMACEUTICALS (DRUGS
AND BIOLOGICALS)
IMPORT
SISPOM
(National System on D&F Control)
IMPORT
QUALITY, SAFETY, and EFFICACY
of PHARMACEUTICALS
EXPORT
EXPORT
SISPOM
REGISTRATION DOSSIER
 Registration dossier for all
pharmaceutical products (drug and
biological products) should be
submitted in ACTD (ASEAN
Common Technical Dossier) format
in line with ASEAN harmonization.
For further information, please contact :
National Agency of Drug and Food Control (NADFC)
Head of National Agency of Drug and Food Control :
Dra. Kustantinah, Pharmacist, MAppSc.
Website : www.pom.go.id
Jl. Percetakan Negara No. 23
Jakarta – 10560
Indonesia
Phone : 62 21 4244691 / 42883309 / 42883462
Fax : 62 21 4263333
E-mail address : [email protected]
PT BINA SAN PRIMA
GENERAL TRADING & DISTRIBUTOR
 PT Bina San Prima was established in 1994
 38 branches and 17 sub distributors throughout Indonesia
 Total 4,035 employees including 155 sales supervisor, 755 salesmen
 Vehicle : 355 canvassing cars, 142 motor boxes
COMPETITIVE ADVANTAGES
• Strong financial back up
• Same day delivery service
• Strong field forces
• Excellent coverage
• Computer integrated information system
• Nationwide distribution network
• Professionally managed
PRODUCT CATEGORY
Pharmaceutical products
(human & veterinary)
Herbals
PRINCIPAL
PT Sanbe Farma, PT Caprifarmindo
PT Air Mancur, PT Mulya Putra Mandiri
PT Mead Johnson Indonesia
Food & Beverages (cheese,
biscuit, dairy product, cooking oil) PT Ultra Jaya, PT Kraft Food Indonesia
PT Indofood, PT Siantar Top, etc.
Confectionaries
PT Perfetti van Melle, PT Tora Nusantara
Personal Care
PT Beiersdorf, PT Dua Berlian
Other consumer products
(lighting, lubricant oil)
PT Shell Indonesia, PT Philips Indonesia
ACHIEVEMENT AWARDS
AWARDS
PRINCIPAL
The Best Achievement of Business Plan 2009
Shell Companies in Indonesia
Best Revenue Growth Semester I 2009
PT Kraft Food Indonesia
Best Growth Distribution 2009 category A,B,C
PT Nutrifood Indonesia
Top 5 Best Volume Achievement 2008
Shell Companies in Indonesia
HSSE Award 2008
Shell Companies in Indonesia
Top 5 Best Regional Distributor 2008
PT Beiersdorf Indonesia
5 Years Distribution Service
PT Nutrifood Indonesia
ACHIEVEMENT AWARDS
AWARDS
PRINCIPAL
The Best Target Achievement 2007
PT Reckitt Benckiser Indonesia
The Runner Up Volume Growth 2007
Shell Companies in Indonesia
The Best Volume Achievement West Java
2007
Shell Companies in Indonesia
The Best Volume Achievement Palembang
2007
Shell Companies in Indonesia
The Best in Operation Excellence 2006
Shell Companies in Indonesia
The Best Growth 2006
Shell Companies in Indonesia
The Best Target Achievement 2005
PT Reckitt Benckiser Indonesia
The Best Performance 2005
PT Nutrifood Indonesia
The Best Business Growth 2004
PT Procter & Gamble Indonesia
Contact Us :
PT BINA SAN PRIMA
Operation & Brand Director : Andi MS
 E-mail address : [email protected]
 Phone : +62 22 4207725 ext. 502 – 503
 Fax : +62 22 4261031
 Jl. Purnawarman 47
Bandung 40116
West Java - Indonesia
CONCLUSION
 The Indonesian Pharmaceutical market is still
potential enough considering the population number,
GDP and drug consumption per capita
 NADFC as the regulatory authority in Indonesia
commits to treat the foreign and domestic
pharmaceutical companies with same standard and
requirement.
Presented by :
Drs. Jahja Santoso, Pharmacist
Honorary Consul of The Republic of Latvia
For West Java & Bali
June 07, 2011
Indonesia Consumers’ Characteristics
 30 millions live in big city with sufficient buying
power
 100 millions low buying power, 38 millions poor
 60% live in Java island, 21% in Sumatera
 58% live in rural area, 42% in city
 87% Moslems (200 millions) : need Halal Foods
 55% < 25 years old
 480 ethnics in Indonesia
 Rice is a main staple food
Characteristics of Food & Beverages
Business in Indonesia
 Total consumption of Food & Beverages &
tobacco in 2009 : +/- Rp 1,700 trillion
 Fresh & unprocessed foods : +/- Rp 1,000 trillion
 Consumption of processed foods : +/- Rp 505
trillion
 Consumption of cigarettes & processed tobacco:
+/- Rp 120 trillion
 Many malls & modern retails are built (Mini / Super
/ Hypermarket)
Note : USD 1 = Rp 9,000
Characteristics of Food & Beverages
Business in Indonesia
Competitive Environment
 1,159,983 food & beverages industries consist of :
- 6,316 big / medium industries
- 66,178 small industries
- 1,087,489 home industries
 10,226,595 units of wholesaler/retailer
 Multinational companies have entered food & beverages industry, modern
retail, fast food, hotel, restaurant and plantation.
 Imported raw material is still relatively high (e.g. flour, milk, soybean, meat)
Output of Food Industries in Indonesia
2003 - 2008
( in million US$)
Scale of
Industry
Year
2003
2004
2005
2006
2007
2008*
Big &
Medium
18,043
19,035
22,673
29,396
37,283
48,443
Small
1,261
1,509
2,412
4,107
3,035
3,330
Home
industry
2,165
2,243
2,367
4,575
4,404
4,400
Total **)
21,469
22,787
27,452
38,078
44,722
56,173
Source : Statistic of Indonesia 2009, Central Bureau of Statistics
( *) temporary data
EXPORT & IMPORT OF PROCESSED FOODS
(2003 – 2009*) (in million US$)
2003 2004 2005 2006
Export
Import
1,24
2
798
2007
2008
2009*
1,51
9
1,80
6
1,96
2,264
6
2,997
2,060*
827
1,08
6
1,21
1,950
6
1,903
1,224**
Sumber : Central Bureau of Statistics 2009
(*) Jan – Sept’ 2009
(**) Jan - Nov’ 2009
Stakeholder Support
Employees
Customers
Regulators
BSN*
INDUSTRY/
ASSOCIATION
Government /
Institutions
Society /
MASTAN
* BSN = National Standardization Agency of Indonesia
For further information, please contact :
INDONESIAN FOOD & BEVERAGES ASSOCIATION
CHAIRMAN
: Adhi Lukman
SECRETARY GENERAL
: Franky Sibarani
(e-mail address : [email protected])
Head of Secretariat: Virocano Hengki
Email: [email protected]
Data Center & Information: Tri Cahyanto (Nanang)
Email: [email protected]
IT & Back Office: Bobby Kusumo
Email: [email protected]
INDONESIAN FOOD & BEVERAGES ASSOCIATION
Office Address :
Head Office of Ministry of Agriculture
Building F 2nd Floor, Room No. 224-A
Jl. Harsono RM No. 3 Ragunan - Pasar Minggu
Jakarta 12550
Phone
: +62 21 70322626-27
Fax. : +62 21 7804347
website: www.gapmmi.or.id
email : [email protected]
Pulp & Paper Industry
FOREIGN INVESTMENT REALIZATION IN PULP & PAPER INDUSTRY
(January 1, 2005 to December 31, 2009)
Year
Country
Investment value (in thousand USD)
2005
Singapore
5,336
2006
Mauritius
Seychel
USA
South Korea
Singapore
377,124
270,668
21,100
3,620
50
2007
Taiwan
Seychel
Netherland
417,866
235,218
196
2008
Mixed countries
123,762
2009
Singapore
UK
Mixed countries
South Korea
39,815
9,995
6,578
3,300
Wood Industry
FOREIGN INVESTMENT REALIZATION IN WOOD INDUSTRY
(January 1, 2005 to December 31, 2009)
Year
Country
Investment value (in thousand USD)
2005
Japan
Hongkong
South Korea
Taiwan
China
Malaysia
USA
Germany
Mixed countries
1,610
62,659
505
1,100
177
8,281
412
240
512
2006
Japan
South Korea
Taiwan
Singapore
Pakistan
Australia
Mixed countries
7,364
1,871
1,025
23,162
250
650
24,574
Wood Industry
FOREIGN INVESTMENT REALIZATION IN WOOD INDUSTRY
(January 1, 2005 to December 31, 2009)
Year
Country
Investment value (in thousand USD)
2007
Mauritius
Singapore
Japan
Mixed countries
South Korea
55,025
48,183
14,450
7,030
3,165
2008
Japan
Singapore
Malaysia
China
Mixed countries
Taiwan
South Korea
Australia
Denmark
38,644
32,388
25,000
13,845
3,625
2,570
1,595
1,350
450
Wood Industry
FOREIGN INVESTMENT REALIZATION IN WOOD INDUSTRY
(January 1, 2005 to December 31, 2009)
Year
2009
Country
Singapore
Mixed countries
Japan
Taiwan
Hongkong
South Korea
UK
Pakistan
Investment value (in thousand USD)
32,332
21,534
5,025
879
878
800
350
300
For further information, please contact :
* ASSOCIATION OF INDONESIA PULP & PAPER
 Chairman : M. Mansur
 Secretary General : Kahar Haryoppuspito
 Office Address :
Jl. Cimandiri 6 Flat 1 No. 2
Jakarta 10330
Phone
: +62 21 3192 6084
Fax
: +62 21 3911 1351
E-mail
: [email protected]
For further information, please contact :
* INDONESIAN WOOD PANEL PRODUCERS ASSOCIATION
 Chairman : Martias
 Secretary General : AA Malik
 Office Address :
Manggala Wanabakti Building
Block IV Wing A 9th Floor
Jl. Jend. Gatot Subroto
Jakarta 10270
Phone
: +62 21 5711 290
Fax
: +62 21 5733 017 / 5733 015
E-mail
: [email protected]
For further information, please contact :
* INDONESIAN SAWMIL & WOOD WORKING MANUFACTURERS
ASSOCIATION
 Chairman : Dra. Hj. Soewarni. MM
 Secretary General : Drs. Sri Oetom
 Office Address :
Manggala Wanabakti Building
Block IV Wing C 8th Floor
Jl. Jend. Gatot Subroto
Jakarta 10270
Phone
: +62 21 5733 018
Fax
: +62 21 5711 327 / 5734 385
E-mail
: [email protected]
Thank You For Your Kind Attention
Drs. Jahja Santoso, Pharmacist
Honorary Consul of The Republic of Latvia
For West Java & Bali
June 07, 2011
Descargar

SPEAKER’S PROFILE Drs. Jahja Santoso, Pharmacist